Drugs & TargetsFree FDA approves mitomycin for low-grade upper tract urothelial cancer April 17, 2020Vol.46 No.16
Drugs & TargetsFree Ontruzant, biosimilar of Herceptin, introduced in the U.S. April 17, 2020Vol.46 No.16
Drugs & TargetsFree FDA approves Braftovi + cetuximab for BRAFV600E-mutant metastatic CRC indication April 10, 2020Vol.46 No.15
Drugs & TargetsFree FDA approves luspatercept-aamt for anemia in adults with MDS April 10, 2020Vol.46 No.15
Drugs & TargetsFree Myriad receives reimbursement for the BRACAnalysis Diagnostic System in Japan April 10, 2020Vol.46 No.15
Drugs & TargetsFree EMA grants positive opinion to Adcetris combination in lymphoma indication April 03, 2020Vol.46 No.14
Drugs & TargetsFree China accepts sNDA for Zejula in ovarian cancer indication March 20, 2020Vol.46 No.12
Drugs & TargetsFree The U.K. removes Keytruda from Cancer Drug Fund in bladder cancer indication March 20, 2020Vol.46 No.12
Drugs & TargetsFree FDA approves Herzuma, equivalent of Herceptin, in indications March 20, 2020Vol.46 No.12
